May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
The BPEI–InnFocus Glaucoma Drainage Implant – The MiDi: Concept, Physics and Pressure Control
Author Affiliations & Notes
  • L. Pinchuk
    InnFocus LLC, Miami, FL
    Biomedical Engineering, University of Miami, Miami, FL
  • F. Fantes
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL
  • Y. Zhou
    InnFocus LLC, Miami, FL
  • J.B. Martin
    InnFocus LLC, Miami, FL
  • J.–M. Parel
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL
    Univ of Liege, CHU Sart–Tilman, Liege, Belgium
  • Footnotes
    Commercial Relationships  L. Pinchuk, InnFocus LLC, I; InnFocus LLC, E; InnFocus LLC, P; F. Fantes, InnFocus LLC, F; InnFocus LLC, P; Y. Zhou, InnFocus LLC, E; J.B. Martin, InnFocus LLC, E; J. Parel, InnFocus LLC, F; InnFocus LLC, P.
  • Footnotes
    Support  InnFocus LLC, Miami FL; NIH center grant P30–EY014801; Florida Lions Eye Bank; Research to Prevent Blindness; the Henri and Flore Lesieur Foundation.
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 36. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Pinchuk, F. Fantes, Y. Zhou, J.B. Martin, J.–M. Parel; The BPEI–InnFocus Glaucoma Drainage Implant – The MiDi: Concept, Physics and Pressure Control . Invest. Ophthalmol. Vis. Sci. 2006;47(13):36.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Drainage tubes perform well in the long term for the chronic treatment of glaucoma; however, they are difficult to implant, often cause acute hypotony, encapsulate and hinder mobility, and are difficult to remove or add devices in the event that they fail. A novel biomaterial, poly(styrene–b–isobutylene–b–styrene) ("SIBS"), that does not provoke scar tissue or encapsulation in the eye has enabled the development of a valveless micro–tubular device that that can easily be implanted in the eye through a 27g needle.

Methods: : The MiDi is made from SIBS, a biocompatible biostable material that is very soft and flexible and conforms to the curvature of the eye. It is 11mm long, 250µm in OD and nominally 70, 100 or 150µm in lumen diameter. Integral to the tubular device is a 1mm2 tab which prevents the device from migrating. The shunt is implanted through a 27g needle tract formed in a conjunctival dissection beginning 2mm below the limbus and exiting in the angle. The MiDi is passed through the tract using a special inserter and rests with its proximal tip 2mm into the AC and the distal end in the flap near the equator. The Hagen–Poiseuille equation was used to calculate lumen diameter for a given length to reduce IOP without causing hypotony. Calculations through the 70, 100 and 150µm MiDi’s, at a pressure head of 20mmHg, predict flow rates of 11, 70 and 360µL/min., respectively.

Results: : Actual flow measurements are 6.5, 60 and 347µL/min, respectively, which deviate from theoretical by 40, 14 and 3.6%, respectively. The decreasing error trend is predominantly due to 1), breakdown of the Hagen–Poiseuille equation at very small diameters where the surface tension of the fluid begins to play a predominant role and 2) the sensitivity of flow rate as a function of the fourth power of lumen diameter with the inability to measure lumen diameter accurately. Pressure decay curves through the 70, 100 and 150µm tubes from an initial 20mmHg pressure head with concomitant flow from a syringe pump of 2.5µL/min through the device; indicate asymptotes at 9.0, 1.5 and 0.3mmHg, respectively when the exit of the device is exposed to air.

Conclusions: : The Hagen–Poiseuille equation is sufficiently accurate to show the trends of pressure drop and flow rate for the three sizes tested without the need for a pressure control valve.

Keywords: intraocular pressure • aqueous • trabecular meshwork 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.